IdeaWell

Project ideas from Hacker News discussions.

Founder of GitLab battles cancer by founding companies

Original Article

Hacker News Discussion

📝 Discussion Summary (Click to expand)

1. Wealth & access open a unique pathway to self‑directed medical action

“none of this would have been possible without his unfathomable wealth and access.” — twostorytower

2. Personal agency drives the fight‑against‑disease

“It became my own job to keep myself alive. Nobody else was going to do it for me at this point.” — sytse

3. The meaning of “unfathomable wealth” is fiercely debated – even $3 B is only “entry‑level”

“It’s entry‑level billionaires club. The top 10 each hold $100B–$300B+, so the wealth distribution is extraordinarily skewed even within billionaires themselves.” — perch56

4. The community reacts with admiration, inspiration, and a call for broader access

“This is wonderful but I feel bad for all the people who don’t have the resources to go through the same.” — appstorelottery

🚀 Project Ideas

Patient IND Assistant

Summary

  • Automates the entire FDA “single‑patient IND” workflow for individuals seeking experimental cancer treatments.
  • Turns a daunting regulatory maze into a guided checklist with document generation, submission tracking, and compliance alerts.

Details| Key | Value |

|-----|-------| | Target Audience | Patients, caregivers, and citizen‑scientists with advanced disease who want to access investigational therapies. | | Core Feature | Step‑by‑step IND builder, AI‑reviewed protocol drafting, auto‑filled FDA forms, and a real‑time status dashboard. | | Tech Stack | React front‑end, Node.js API, Flask for FDA‑XML processing, FastAPI for AI drafting, PostgreSQL, Docker, Stripe for payments. | | Difficulty | Medium | | Monetization | Revenue-ready: $49/month subscription + one‑time $199 “Premium Submission” fee. |

Notes

  • HN users repeatedly lamented the “bureaucracy‑blocking” hurdles Sid overcame; this tool would give ordinary people the same shortcut.
  • Could integrate with existing patient forums to surface real‑world experiences, creating a community‑driven knowledge base.

BioData Mesh

Summary

  • Decentralized platform for sharing anonymized tumor sequencing and clinical‑response data to power AI‑driven treatment hypotheses.
  • Enables patients and researchers to contribute data and receive personalized insight without proprietary lock‑in.

Details

Key Value
Target Audience Cancer patients, bioinformaticians, and decentralized research communities seeking transparent data sharing.
Core Feature Immutable data shards on IPFS, federated learning models that generate treatment‑response predictions, and a query UI for “what‑if” scenarios.
Tech Stack Angular front‑end, Rust backend, IPFS clustered storage, Polkadot parachain for data provenance, PyTorch for federated models, Web3 auth.
Difficulty High
Monetization Revenue-ready: 2% royalty on any commercial licensing of insights derived from user‑contributed data.

Notes

  • Commenters admired Sid’s openly shared datasets and “maximum diagnostics” approach; a community‑governed mesh would let many replicate his data‑driven experimentation.
  • Potential to become a hub for open‑source oncology research, sparking discussion on data ethics and equitable access.

MicroTrial Matcher#Summary

  • AI‑powered marketplace that instantly matches patients to active clinical trials, compassionate‑use programs, and off‑label drug access pathways.
  • Reduces the months‑long search that many patients face, especially those without wealth‑driven connections.

Details

Key Value
Target Audience Patients, caregivers, and advocacy groups looking for experimental treatment options beyond traditional hospital referrals.
Core Feature Conversational AI chatbot that ingests a patient’s medical record (via secure upload), maps eligibility criteria across 30k+ trials, and ranks matches by proximity, remission odds, and cost.
Tech Stack Vue.js UI, GraphQL API, Python backend with LangChain LLM, Elasticsearch for trial indexing, Twilio for SMS alerts, AWS for HIPAA‑compliant storage.
Difficulty Medium
Monetization Revenue-ready: $0.99 per matched trial + 5% of any resulting trial enrollment fee collected from sponsors.

Notes

  • HN discussions highlighted the frustration of “lack of access” for non‑ultra‑rich patients; this service directly addresses that gap.
  • Could be promoted in cancer‑support subreddits and patient forums, generating active community feedback loops.

Rapid Diagnostic Query Engine

Summary

  • A searchable knowledge engine that translates raw clinical‑lab results, genomic reports, and imaging studies into actionable treatment hypotheses within minutes.
  • Empowers anyone with public‑facing diagnostic data to explore personalized therapeutic options instantly.

Details

Key Value
Target Audience Patients with direct‑to‑consumer lab results (e.g., 23andMe, whole‑genome kits) and self‑diagnosed chronic conditions seeking fast insight.
Core Feature Natural‑language query interface that ingests PDF pathology reports, extracts variants, cross‑references them with curated drug‑target databases, and returns ranked therapeutic recommendations with evidence levels.
Tech Stack SvelteKit front‑end, Django backend, PostgreSQL with PostGIS for geographic trial locations, GPT‑4‑Turbo for report parsing, HuggingFace embeddings for similarity search, Cloudflare Workers for edge inference.
Difficulty Low
Monetization Hobby

Notes

  • Commenters admired Sid’s ability to “read the data and act”; this tool would let ordinary users emulate that analytical speed without needing elite expertise.
  • Has clear potential for viral discussion on platforms like HN and Reddit, especially among bio‑hacking communities.

Read Later